Back to News

Here are the 5 Pharma Giants that will be Affected by the Ban on FDCs

October 03, 2018

Here are the 5 Pharma Giants that will be Affected by the Ban on FDCs

With the health ministry imposing a ban on 328 fixed-dose combination (FDC) drugs, 5 of the biggest pharmaceutical companies find themselves in jeopardy. These are Macleods Pharmaceuticals, FDC Ltd., Mankind Pharmaceuticals, Medley Pharmaceuticals, and Alkem. Out of these, Macleods Pharmaceuticals has the largest share in the market and does nearly 3 billion in sales in a year. 

The banned 328 FDCs make for 0.8% of the market share at 10.40 billion in sales. The ban itself was imposed because the ministry found these drugs to be irrational and lacking any therapeutic justification.

Photo on Visual Hunt

Important Links:

Consult a Career Advisor

Fill up the form to get in touch with us.

Recent Posts
Subsidies to Indian Farmers Much Lower in Contrast to Western Countries, Says Commerce Secretary
March 29, 2019
Transaction Monitoring Market to Grow 200% by 2023, Says Report
March 29, 2019
90% CAGR Growth Expected in Blockchain IoT Market, Could Reach 3,000 mn USD in 5 Years
March 29, 2019

Recommended for you ...

Subsidies to Indian Farmers Much Lower in Contrast to Western Countries, Says Commerce Secretary
Subsidies to Indian Farmers Much Lower in Contrast to Western Countries, Says Commerce Secretary

March 29, 2019

Transaction Monitoring Market to Grow 200% by 2023, Says Report
Transaction Monitoring Market to Grow 200% by 2023, Says Report

March 29, 2019

90% CAGR Growth Expected in Blockchain IoT Market, Could Reach 3,000 mn USD in 5 Years
90% CAGR Growth Expected in Blockchain IoT Market, Could Reach 3,000 mn USD in 5 Years

March 29, 2019

Chat on WhatsApp